Table I.
Baseline characteristics of the studies included.
A, ESWT vs. placebo | ||||||
---|---|---|---|---|---|---|
First author, year | OA joints included | Size of intervention group (ESWT), n | Size of control group (placebo), n | Outcomes | Follow-up | (Refs.) |
Chen et al, 2014 | Bilateral knees | 30 | 30 | 1. ROM | After 8 weeks (physical and placebo) | (18) |
2. VAS (after walking or standing 5 min) | After 6 weeks (ESWT) | |||||
3. Li | ||||||
Cho et al, 2016 | Bilateral knees or unilateral knees | 9 | 9 | After 1 week | (19) | |
Elerian et al, 2016 | Bilateral knees | 20 | 20 | VAS | WOMAC | (20) |
ROM | After 8 weeks | |||||
Imamura et al, 2017 | Bilateral knees | 52 | 53 | VAS | After 12 weeks | (15) |
WOMAC | ||||||
Zhao et al, 2013 | Unilateral OA or more painful side | 30 | 31 | 1. VAS | After 4 weeks and 12 weeks | (21) |
2. LI | ||||||
3. WOMAC | ||||||
B, ESWT vs. physical therapy | ||||||
First author, year | OA joints included | Size of intervention group (ESWT), n | Size of control group (placebo), n | Outcomes | Follow-up | (Refs.) |
Chen et al, 2014 | Bilateral knees | 30 | 30 | 1. ROM | After 8 weeks (physical and placebo) | (18) |
2. VAS | After 6 weeks (ESWT) | |||||
3. LI | ||||||
Lee et al, 2017 | Bilateral knees | 10 | 10 | 1. VAS | After 4 weeks | (22) |
2. WOMAC | ||||||
Lizis et al, 2017 | Unilateral knee | 20 | 20 | ROM | After 5 weeks | (23) |
WOMAC |
OA, osteoarthritis; ESWT, extracorporeal shockwave therapy; ROM, range of motion; VAS, visual analogue scale; LI, Lequesne index; WOMAC, Western Ontario and McMaster Universities osteoarthritis index.